CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2025-09-11 12:21Core Viewpoint - Xiangsheng Medical (688358) has shown a slight increase in stock price, with a closing price of 30.91 yuan on September 11, 2025, reflecting a 1.48% rise, amidst mixed capital flows from different investor types [1][2]. Financial Performance - The company reported a main revenue of 236 million yuan for the first half of 2025, a year-on-year decrease of 4.61% - The net profit attributable to shareholders was 69.7 million yuan, down 14.32% year-on-year - The second quarter of 2025 saw a main revenue of 108 million yuan, a year-on-year increase of 1.37%, while the net profit for the same period was 28.1 million yuan, a decline of 21.57% [3]. Key Financial Metrics - Total market capitalization stands at 3.466 billion yuan, with a net asset value of 1.378 billion yuan - The company has a price-to-earnings ratio (P/E) of 24.86, significantly lower than the industry average of 67.38 - The gross margin is reported at 60.65%, which is higher than the industry average of 51.85% [3]. Capital Flow Analysis - On September 11, 2025, the net inflow of main funds was 4.73 million yuan, accounting for 13.15% of the total transaction volume - Retail investors showed a net outflow of 1.95 million yuan, representing 5.43% of the total transaction volume [1][2]. Industry Ranking - Xiangsheng Medical ranks 99th in total market capitalization and 90th in net assets within the medical device industry - The company ranks 45th in net profit and 20th in price-to-earnings ratio among its peers [3].